Clinical Research

AI helps cardiologists track new drug's effect on inflammation
The combination of AI and CT helped Nehal Mehta, MD, and colleagues track the performance of a new drug designed to target coronary inflammation.
Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?
Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.
Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices
Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.
Cardiologist Sunil Rao highlights importance of DanGer Shock compared to other cardiogenic shock trials
Sunil Rao, MD, director of interventional cardiology at NYU Langone, says DanGer Shock is a "very, very important study" when it comes to the treatment of cardiogenic shock.
PAD patients face greater risk of death, complications after a heart attack
PAD and CLI patients who show signs of coronary heart disease may benefit from early treatment, according to a new study of nearly 4 million hospitalizations.

doctor examines patient data on their tablet

New American College of Cardiology registry focuses on data from outpatient ambulatory surgical centers

The ACC launched its latest registry knowing that volumes at these outpatient facilities are expected to rise in the years ahead.

February 13, 2024

TAVR vs. SAVR after 10 years: Similar safety risks, but researchers uncover several key differences

TAVR continues to gain momentum as a go-to treatment option for severe AS, making it more important than ever to investigate long-term outcomes. This latest analysis, published in European Heart Journal, focused on 280 patients randomized to undergo either transcatheter or surgical aortic valve replacement.

February 7, 2024

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston.

Biosense Webster shares latest data on its pulsed field ablation system

The company, part of Johnson & Johnson MedTech, shared positive data from two different clinical trials at AF Symposium 2024 in Boston.

February 5, 2024

According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.

SAVR in the TAVR era: Volumes are down, but it remains the go-to choice for certain patient populations

Annual SAVR volumes in the United States decreased by a whopping 44.5% from 2012 to 2022. However, heart teams across the country seem to agree that surgery is a safer, more effective treatment option than TAVR when patients present with bicuspid aortic valves.

January 30, 2024

Example of the Esolution device developed by S4 Medical being used during a radiofrequency ablation procedure. Image courtesy of Daoud et al.

New medical device helps cardiologists limit esophageal injuries during RF ablation procedures

Injuries to the esophagus remain a common complication associated with radiofrequency ablation procedures. New research suggests a device developed by S4 Medical could significantly reduce the risk of such injuries.

January 30, 2024

ACC 2023 ACC.23 American College of Cardiology

American College of Cardiology announces late-breaking research for ACC.24 in Atlanta

The group's annual meeting heads to Atlanta this April. TAVR, GLP-1 agonists, medical imaging guidance and blood pressure control are just some of the topics that will be presented during late-breaking sessions.

January 29, 2024

Samin Sharma, MD, director of interventional cardiology and director of clinical cardiology, Mount Sinai Hospital, New York, discusses the first-in-human use of the Magenta Elevate percutaneous left ventricular assist device (pLVAD) with a small 10 French size and 5.5 liters per minute of hemodynamic support.

Initial results promising for world's smallest percutaneous heart pump

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.

January 22, 2024

Pre-clinical images of the Abbott Volt pulsed field ablation system creating lesions using electroporation, presented at the 2023 AHA Scientific Sessions, The Abbott PFA system is now being used in a first-in-human study at the Centre for Heart Rhythm Disorders at the University of Adelaide, Australia.

First patients treated with Abbott’s pulsed field ablation offering

According to Abbott, its Volt system was specifically designed to address weaknesses seen in other first-generation PFA offerings.

January 19, 2024

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Clinical Research

AI helps cardiologists track new drug's effect on inflammation

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?

Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices

Cardiologist Sunil Rao highlights importance of DanGer Shock compared to other cardiogenic shock trials

PAD patients face greater risk of death, complications after a heart attack

Around the web